Bacteriostatic Water · 10 mLIDR 69.600RESEARCH PEPTIDE
Retatrutide 30 mg

Retatrutide 30 mg
Retatrutide is a single-molecule agonist studied across GIP, GLP-1, and glucagon receptors to examine integrated metabolic signalling.
About this research category
GIP, GLP-1 and glucagon receptor research. Study findings do not establish this catalogue material as a treatment or demonstrate its safety.
Labels describe study topics - not proven benefits, personal-use guidance or product compatibility.
Read the primary study ↗IDR 4.500.000
Contact the team to confirm availability and arrange this item directly.
Available from local Bali stock
Eligible in-stock orders confirmed before 5 PM Bali time can receive same-day dispatch, subject to order confirmation and fulfilment arrangements.
Gojek delivery is arranged to your hotel, villa or other Bali destination. Confirm the address, receiving contact and handover window with the team in WhatsApp.
Check Bali delivery areas: Canggu, Seminyak, Ubud & wider Bali →For laboratory and scientific research only · not for human consumption.
Laboratory supplies
Need bacteriostatic water?
Add BAC water to your order if required by your laboratory protocol. Choose the size below; compatibility depends on your research requirements.
Compare bacteriostatic water in Bali: 3 mL & 10 mL →
Bacteriostatic Water · 10 mLIDR 69.600
Bacteriostatic Water · 3 mLIDR 40.000Optional add-on, not added automatically. BAC water does not count towards the peptide-vial discount threshold.
Explore more research materials
Other listings in this category - not a recommendation to combine products.
Retatrutide · 15 mgIDR 2.387.500Research categoryIncretin signalling research
AOD-9604 · 10 mgIDR 2.530.000Research categoryLipid-metabolism research- Product
- Retatrutide
- Strength
- 30 mg
- Category
- Research Peptides
- Purity
- ≥99.6% PURITY
- Use
- Laboratory and scientific research only
- Price
- IDR 4.500.000
- Availability
- 9 in stock
The power of triple-receptor metabolic research.
Retatrutide is a single-molecule agonist studied across GIP, GLP-1, and glucagon receptors to examine integrated metabolic signalling.
Research context
Preclinical pharmacology characterises retatrutide as a triple agonist across GIP, GLP-1, and glucagon receptors. Its research value lies in studying how these pathways interact across glucose, appetite, and energy-expenditure signalling without promising weight-loss or treatment outcomes.
Research interests
- Triple-receptor pharmacology
- Incretin and glucagon signalling
- Metabolic-pathway crosstalk


